Sally Del Principe
Corporate Officer/Principal bei Lupton del Principe Associates Ltd.
Profil
Sally Del Principe is currently a Partner at Lupton del Principe Associates Ltd.
where she has worked since 1992.
Previously, she worked as the Chief Financial Officer at HIV-VAC, Inc. from 2001 to 2010.
Aktive Positionen von Sally Del Principe
| Unternehmen | Position | Beginn |
|---|---|---|
| Lupton del Principe Associates Ltd. | Corporate Officer/Principal | 09.04.2010 |
Ehemalige bekannte Positionen von Sally Del Principe
| Unternehmen | Position | Ende |
|---|---|---|
HIV-VAC, Inc.
 HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Finanzdirektor/CFO | 28.10.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
HIV-VAC, Inc.
HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Commercial Services |
| Lupton del Principe Associates Ltd. |
